Gain Therapeutics, Inc.
GANX
Revenue
55.18k
▲180.35k▲144.08%
3 Months ChangeAssets
19.20M
▲4.62M▲31.69%
3 Months ChangeLiabilities
7.41M
▲1.48M▲24.87%
3 Months ChangeFree Cash Flow
-4.23M
▼-1.77M▼-72.22%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-21
Form 8-K
ID: 0001104659-24-110287
2024-10-08
Form 8-K
ID: 0001104659-24-107052
2024-09-06
Form 8-K
ID: 0001104659-24-097781
2024-08-08
Form 10-Q
ID: 0001558370-24-011589
2024-08-08
Form 8-K
ID: 0001558370-24-011585
2024-07-12
Form 8-K
ID: 0001104659-24-079601
2024-07-09
Form 8-K
ID: 0001104659-24-078600
2024-06-28
Form 8-K
ID: 0001104659-24-076341
2024-06-25
Form 8-K
ID: 0001104659-24-074822
2024-06-14
Form 8-K
ID: 0001104659-24-071801